Argus Research Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $110

Benzinga · 2d ago
Argus Research analyst John Eade initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and announces Price Target of $110.